Table 1 Distribution of diagnoses in the Austrian database of 626 WHO-classified patients with MPN

From: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

 

WHO-classified cohort (n=626)

ET

259 (41.4%)

prePMF

225 (36.0%)

PV

116 (18.5%)

PMF

22 (3.5%)

MPN-U

4 (0.6%)

  1. Abbreviations: ET, essential thrombocythemia; MPN-U, myeloproliferative neoplasm-unclassifiable; PMF, advanced PMF; prePMF, prefibrotic primary myelofibrosis; PV, polycythemia vera.
Back to article page